Ventyx Biosciences
VTYX
VTYX was delisted on the 3rd of March, 2026.
121 hedge funds and large institutions have $112M invested in Ventyx Biosciences in 2023 Q4 according to their latest regulatory filings, with 45 funds opening new positions, 31 increasing their positions, 33 reducing their positions, and 61 closing their positions.
6% less repeat investments, than reductions
Existing positions increased: 31 | Existing positions reduced: 33
12% less funds holding
Funds holding: 138 → 121 (-17)
16.19% less ownership
Funds ownership: 92.69% → 76.5% (-16%)
26% less first-time investments, than exits
New positions opened: 45 | Existing positions closed: 61
67% less funds holding in top 10
Funds holding in top 10: 3 → 1 (-2)
86% less call options, than puts
Call options by funds: $426K | Put options by funds: $2.95M
94% less capital invested
Capital invested by funds: $1.9B → $112M (-$1.78B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$33.7M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
+$19M |
| 3 |
Millennium Management
New York
|
+$17.8M |
| 4 |
LGM
Logos Global Management
San Francisco,
California
|
+$16.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$12.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$81.8M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$60.1M |
| 3 |
Holocene Advisors
New York
|
-$55.5M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$46.6M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$45.1M |
VTYX Hedge Fund Activity: Q4 2023 in Review
121 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q4 2023, worth a combined $112M — down 94% from $1.9B a quarter earlier.
Sellers outnumbered buyers: 61 funds closed out of VTYX and 45 opened new positions — a net loss of 16 holders — while 33 trimmed existing stakes and 31 added.
The largest buyer was Morgan Stanley, adding an estimated $33.7M. The largest seller was Fidelity Investments, cutting an estimated $81.8M.
- 121 institutional investors held Ventyx Biosciences (VTYX) as of Q4 2023, down from 138 in Q3 2023.
- Funds reported $112M of Ventyx Biosciences stock for Q4 2023, down 94% quarter-over-quarter.
- 45 funds opened new Ventyx Biosciences positions in Q4 2023 and 61 closed out, a net change of -16 holders.
- The largest Ventyx Biosciences buyer in Q4 2023 was Morgan Stanley, an estimated $33.7M added.
- The largest Ventyx Biosciences seller in Q4 2023 was Fidelity Investments, an estimated $81.8M sold.
Based on aggregated 13F filings for Q4 2023.